-
II Symposium for patients with Atopic Dermatitis
FUNDAPSO, one of our GAAPP members in Colombia, will conduct… Read More >
-
World Atopic Eczema Day 2023
For 2023 #WorldEczemaDay, GAAPP has joined Globalskin and EFA “#IfYouOnlyKnew” campaign to amplify the voice of the important testimonials that we recorded for the “AD Caregivers Academy Project” Read More >
-
Device4Patients – Respiramo Insieme (Italy)
The project guide both patients and healthcare professionals on the correct use of inhalation devices. This project was supported by GAAPP. Read More >
-
GAAPP Staff Announcement
The Global Allergy & Airways Patient Platform (GAAPP) is excited… Read More >
-
The lack of access to CRDs treatment in Ecuador
GLOBAL PATIENT ORGANIZATIONS JOIN FORCES TO DEMAND THAT ECUADOR’S GOVERNMENT… Read More >
-
SAREAL 2023
SAREAL 2023 As part of the A16 ALAT Congress, GAAPP and Latin Health… Read More >
-
Urtikaria-Helden Global Survey on Urticaria Patients
GAAPP is supporting its member, Urtikaria-Helden, to generate patient-reported evidence… Read More >
-
GAAPP Board of Directors Nomination
The Global Allergy and Airways Patient Platform (GAAPP) is committed… Read More >
-
World Bronchiectasis Day Educational Webinar
In the context of the 2nd World Bronchiectasis Day, which… Read More >
-
Ruth Tal-Singer joins GAAPP as Chief Scientific Officer
The Global Allergy & Airways Patient Platform (GAAPP) is pleased to announce Ruth Tal-Singer, Ph.D., is joining as Chief Scientific Officer. Read More >
-
Severe Asthma Index: Guiding Countries Towards Effective Severe Asthma Management
The Severe Asthma Index has been in development for over a year, engaging the global severe asthma community and measuring over 600 quantitative and qualitative data references against 28 indicators to create five key measurement categories. Read More >